Consolidated Statements of Operations and Comprehensive Loss (USD $)	12 Months Ended		69 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Revenues	$ 0	$ 0	$ 10,188
Operating expenses:
Research and development	365,910	50,000	415,910
General and administrative	549,315	171,543	803,147
Impairment of long-lived assets	0	919	919
Total operating expenses	915,225	222,462	1,219,976
Loss from operations	(915,225)	(222,462)	(1,209,788)
Other income:
Interest income	749	0	749
Foreign currency exchange gain	3,958	0	3,958
Total other income	4,707	0	4,707
Net loss	(910,518)	(222,462)	(1,205,081)
Other comprehensive loss:
Foreign currency translation gain	1,899	0	1,899
Total comprehensive loss	$ (908,619)	$ (222,462)	$ (1,203,182)
Net loss per common share - basic and diluted	$ 0.00	$ 0.00
Weighted average number of common shares outstanding - basic and diluted	377,921,835	797,038,934